Dyax Corp. (NASDAQ:DYAX)

majakblue (< 20) Submitted: 4/14/2007 3:19:13 PM : Start Price: $6.19 DYAX Score: +68.14

Yeah, yeah, yeah, lets see if any of their candidates get past large scale phase III trials. Lets see if the patients have kidneys and liver left afterwards.

j3bajric (< 20) Submitted: 4/13/2007 2:16:00 PM : Start Price: $5.92 DYAX Score: -67.41

If it gets approved money will flow.

wbahl (81.60) Submitted: 4/13/2007 11:05:35 AM : Start Price: $6.21 DYAX Score: -68.83

This company researches cancer and is very successful.

beefsteakfarmer (31.09) Submitted: 3/13/2007 10:42:54 AM : Start Price: $3.95 DYAX Score: -56.51

The immediate future may not be encouraging but the long term will outperform the s&p. Look for the place to get in and then exit when the dx-88 sends the stock soaring for a little while.

mesomatt (< 20) Submitted: 2/17/2007 10:06:04 AM : Start Price: $4.65 DYAX Score: -59.55

this new drug that they are coming out with will most likely get accepted to distribute throughout the public. if it does, the prices will soar for the next few months. im not sure how the long term will do though.

BigGMan52 (< 20) Submitted: 2/16/2007 6:37:58 AM : Start Price: $4.51 DYAX Score: -58.49

First product in late phase testing and is expected to gain approval in 2008. Product pipeline in place to insure ongoing success. I expect this stock to gain momentum as late phase testing moves toward approval

arsenalfc14 (72.22) Submitted: 2/13/2007 9:44:18 PM : Start Price: $3.83 DYAX Score: -52.18

THis stock is Great.

CanadasFinest (< 20) Submitted: 2/2/2007 11:14:06 PM : Start Price: $3.25 DYAX Score: -44.28

The Drugs in the pipeline are about to make this stock soar.

wincopr (57.27) Submitted: 11/21/2006 1:37:33 PM : Start Price: $3.06 DYAX Score: -43.79

Great drug to be developed. Drug trials are passed, strong buy recommendation.